| Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors I Marinoni, AS Kurrer, E Vassella, M Dettmer, T Rudolph, V Banz, ... Gastroenterology 146 (2), 453-460. e5, 2014 | 434 | 2014 |
| Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma M Dettmer, A Perren, H Moch, P Komminoth, YE Nikiforov, MN Nikiforova Thyroid 23 (11), 1383-1389, 2013 | 142 | 2013 |
| MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas M Dettmer, A Vogetseder, MB Durso, H Moch, P Komminoth, A Perren, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), E1-E7, 2013 | 134 | 2013 |
| MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights MS Dettmer, A Perren, H Moch, P Komminoth, YE Nikiforov, ... J Mol Endocrinol 52 (2), 181-189, 2014 | 97 | 2014 |
| Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms S Stivala, T Codilupi, S Brkic, A Baerenwaldt, N Ghosh, H Hao-Shen, ... The Journal of clinical investigation 129 (4), 1596-1611, 2019 | 91 | 2019 |
| Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? M Dettmer, A Schmitt, H Steinert, A Haldemann, A Meili, H Moch, ... Am J Surg Pathol. 35 (12), 1866-1872, 2011 | 85 | 2011 |
| The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model P Häfliger, J Graff, M Rubin, A Stooss, MS Dettmer, KH Altmann, J Gertsch, ... Journal of experimental & clinical cancer research 37, 1-15, 2018 | 83 | 2018 |
| Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT MS Dettmer, A Schmitt, H Steinert, D Capper, H Moch, P Komminoth, ... Endocrine-related cancer 22 (3), 419-429, 2015 | 83 | 2015 |
| Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression A Di Domenico, CP Pipinikas, RS Maire, K Bräutigam, C Simillion, ... Communications biology 3 (1), 740, 2020 | 69 | 2020 |
| Targeting CD47 in anaplastic thyroid carcinoma enhances tumor phagocytosis by macrophages and is a promising therapeutic strategy CM Schürch, MA Roelli, S Forster, MH Wasmer, F Brühl, RS Maire, ... Thyroid 29 (7), 979-992, 2019 | 67 | 2019 |
| Salivary gland macrophages and tissue-resident CD8+ T cells cooperate for homeostatic organ surveillance B Stolp, F Thelen, X Ficht, LM Altenburger, N Ruef, VVGK Inavalli, ... Science immunology 5 (46), eaaz4371, 2020 | 64 | 2020 |
| Poorly differentiated oncocytic thyroid carcinoma–diagnostic implications and outcome M Dettmer, A Schmitt, H Steinert, H Moch, P Komminoth, A Perren Histopathology 60 (7), 1045-1051, 2012 | 62 | 2012 |
| Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type? E Vassella, S Langsch, MS Dettmer, C Schlup, M Neuenschwander, ... Oncotarget 6 (27), 23905, 2015 | 57 | 2015 |
| The positive impact of cytological specimens for EGFR mutation testing in non‐small cell lung cancer: a single South East Asian laboratory’s analysis of 670 cases B Pang, D Matthias, CW Ong, AN Dhewar, S Gupta, GL Lim, ME Nga, ... Cytopathology 23 (4), 229-236, 2012 | 56 | 2012 |
| Ex vivo evaluation of coronary atherosclerotic plaques: characterization with dual-source CT in comparison with histopathology S Leschka, S Seitun, M Dettmer, S Baumüller, P Stolzmann, R Goetti, ... Journal of cardiovascular computed tomography 4 (5), 301-308, 2010 | 53 | 2010 |
| Combined ATRX/IDH 1 immunohistochemistry predicts genotype of oligoastrocytomas E Hewer, I Vajtai, MS Dettmer, S Berezowska, E Vassella Histopathology 68 (2), 272-278, 2016 | 39 | 2016 |
| A neuromonitoring approach to facial nerve preservation during image-guided robotic cochlear implantation J Ansó, C Dür, K Gavaghan, H Rohrbach, N Gerber, T Williamson, ... Otology & neurotology 37 (1), 89-98, 2016 | 38 | 2016 |
| Diagnostic and prognostic implications of the PAX8–PPARγ translocation in thyroid carcinomas—a TMA‐based study of 226 cases LA Boos, M Dettmer, A Schmitt, T Rudolph, H Steinert, H Moch, ... Histopathology 63 (2), 234-241, 2013 | 36 | 2013 |
| Poorly differentiated thyroid carcinoma: an underdiagnosed entity MS Dettmer, A Schmitt, P Komminoth, A Perren Der Pathologe 41 (Suppl 1), 1, 2020 | 31 | 2020 |
| Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo O ElMokh, D Ruffieux-Daidié, MA Roelli, A Stooss, WA Phillips, J Gertsch, ... Oncotarget 8 (15), 24604, 2017 | 28 | 2017 |
Aurel PerrenInstitut für Gewebemedizin und Pathologie, University of BernVerified email at unibe.ch
